Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
108 studies found for:    "Kidney Diseases, Cystic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT
Conditions: Cystic Renal Diseases;   Kidney Neoplasms
Interventions: Other: Blood/urine sampling;   Other: Conventional routine CT examination;   Other: Contrast-enhanced renal ultrasonography (CEUS);   Other: Functional MRI
2 Recruiting Contrast-enhanced Ultrasound of the Kidney
Conditions: Chronic Kidney Disease;   Cystic Kidney Disease
Intervention: Drug: Perflutren lipid microsphere
3 Recruiting Contrast-enhanced Ultrasound for the Evaluation of Complex Renal Cysts
Condition: Complex Renal Cyst
Intervention: Procedure: Contrast-enhanced ultrasound
4 Unknown  UAB Recessive PKD Research and Translational Core Center
Condition: Autosomal Recessive Polycystic Kidney Disease
Intervention:
5 Recruiting Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Tolvaptan;   Drug: Matching Placebo
6 Recruiting Using Preimplantation Genetic Diagnosis in Autosomal Dominant Polycystic Kidney Disease Patients: a Multicenter Clinical Trial
Condition: Polycystic Kidney, Type 1 Autosomal Dominant Disease
Intervention: Procedure: Preimplantation Genetic Diagnosis
7 Recruiting Early-Stage Polycystic Kidney Disease Biomarkers Repository Study
Condition: Polycystic Kidney Disease
Intervention:
8 Not yet recruiting A Randomised Feasibility Trial of High Water Intake in Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Dietary Supplement: High water intake;   Other: Ad libitum water intake
9 Recruiting Canadian Medical Assessment of JINARC™ Outcomes Registry
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention:
10 Recruiting Analysis of Clinical and Molecular Genetic Data Influencing the Evolution and Response to Therapy of ADPKD Patients (Autosomal Dominant Polycystic Kidney Disease)
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
11 Recruiting A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
12 Recruiting Effect of Water Intake and Water Restriction on Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease
Condition: ADPKD
Intervention: Other: water
13 Not yet recruiting The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Device: Vessix
14 Not yet recruiting Efficacy of Tolvaptan on ADPKD Patients
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tolvaptan
15 Recruiting Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney Disease
Interventions: Drug: Pioglitazone;   Drug: Placebo
16 Recruiting Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Metformin;   Other: Placebo
17 Active, not recruiting Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Drug: tesevatinib
18 Recruiting Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition: Polycystic Kidney Disease
Interventions: Dietary Supplement: Niacinamide;   Other: Placebo
19 Recruiting Effect of the Aquaretic Tolvaptan on Nitric Oxide System
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan;   Drug: Placebo
20 Recruiting The German ADPKD Tolvaptan Treatment Registry
Condition: ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.